Alexium International Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AXIIF research report →
Price Chart
About the company
Alexium International Group Ltd. engages in the provision of developing chemical solutions. It is involved in the development and licensing of its proprietary flame retardant phase change material, chemicals and reactive surface treatment technologies.
- CEO
- William Timothy Blackburn Jr.
- IPO
- 2007
- Employees
- 29
- HQ
- Greer, SC, US
Get TickerSpark's AI analysis on AXIIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $74.51M
- P/E
- -1.50
- PEG
- 0.03
- P/S
- 3.10
- P/B
- -34.53
- EV/EBITDA
- -3.41
- Div Yield
- 0.00%
- Gross Margin
- 29.10%
- Op Margin
- -98.53%
- Net Margin
- -148.00%
- ROE
- 458.56%
- ROIC
- -428.17%
Latest fiscal year · YoY change
- Revenue
- $4.32M+10.2%
- Gross Profit
- $-2,147,694-227.1%
- Op Income
- $-4,257,310
- Net Income
- $-6,413,921-60.9%
- EPS
- $-0.00-12.0%
- OCF Growth
- -28.9%
- FCF Growth
- -26.8%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.57
- RSI (14)
- 100
- Avg Volume
- 2.47K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Alexium said FY26 was held back by manufacturing disruption and gross margin pressure, but management now sees stabilized operations, new customer placements, and a path back to cash-positive results in the new year.· September 8, 2026
- FY26 revenue grew slightly versus FY25, but gross margin was hurt by a Q4 production issue and inventory write-offs.
- Operating expenses rose as expected after the Microtek acquisition; management said normalized profit would have been about $4.5 million versus the reported $6.2 million.
- Dayton production has been restored and the company says volumes are ramping, with a goal to move 80% of formulated products to Ohio by January.
- Management highlighted new wins in foam, furniture, construction materials, energy conservation, and transportation, plus first orders for AlexiShield in furniture.
- The company said the main near-term priority is execution and cash-positive results, not chasing too many opportunities at once.
Heather said FY26 showed slight revenue growth versus FY25, with higher cost of sales leading to a lower gross margin because of a production issue in the last quarter that has since been resolved but caused inventory write-offs. Operating expenses increased as expected with the acquisition, and after excluding an impairment, the normalized result would have been approximately $4.5 million versus the reported $6.2 million. Management did not give specific revenue, EPS, or gross margin figures on the call. Looking ahead, Billy Blackburn said production has been restored at Dayton and volumes are ramping month over month, with a KPI to move 80% of formulated products to the Ohio facility by around January. He also said the company remains on track to work toward cash-positive results by the new year, with more updates expected in the next 4C at the end of October.
Billy Blackburn framed FY26 as a transition year from technology company to manufacturing-led business, with the acquisition of Microtek creating both operational setbacks and new market opportunities. He said the plant has now stabilized after early maintenance, training, and process issues, and emphasized tighter quality control, lower raw material costs, and better utilization of the Ohio facility. Strategically, he said Alexium wants bedding to become only one part of a more diversified portfolio across foam, furniture, construction materials, energy conservation, and transportation. His tone was candid but upbeat, repeatedly stressing discipline, focus, and execution.
Heather McClain’s remarks centered on the FY26 comparison to FY25: slight revenue growth, higher cost of sales, lower gross margin due to a last-quarter production issue, and higher operating expenses from the acquisition. She said the annual report’s impairment effects mean normalized profit would have been about $4.5 million versus the reported $6.2 million. She did not provide cash, debt, or detailed capital allocation numbers, but the broader financial message was that the company is absorbing acquisition-related costs while trying to improve manufacturing efficiency and restore margin. The capital posture discussed elsewhere on the call was cautious, with management saying no major capital investments are expected in the next quarter and that capacity expansion will be staged and driven by volume.
The main shareholder question was when recent operational improvements would show up in the numbers. Billy said the impact is starting now, and pointed to fourth quarter FY26 into first and second quarter FY27 as the period when new PCM and FR technologies should begin to show in material results, with possible DelCool placement in the new calendar year. Another question asked how the company plans to increase shareholder value and confidence; Billy answered that the only real answer is results, specifically cash-positive results, honoring commitments, and announcing material agreements as they land. The company also deflected the going-concern question to the annual report.
The bullish case from the call is that operational issues at Dayton appear to be behind the company, and management says volumes are now ramping with better leadership and process discipline. Several new commercial paths were highlighted, including AlexiShield in furniture foam, PCM in foam and textiles, and non-bedding opportunities in construction, energy conservation, and transportation. Management sounded more confident that the pipeline is converting into shipments and that the business could reach cash-positive results by the new year.
The bear case is that FY26 was still impacted by manufacturing disruption, inventory write-offs, and lower gross margin from a production issue. Management acknowledged the company lost about 3 to 4 months of momentum during the Dayton transition and is still operating in a soft U.S. bedding market with consumer confidence low. The call also underscored execution risk: multiple new projects are still in development or testing, the Army program is awaiting results, and management’s path to improved financial performance depends on converting a broad pipeline into actual revenue.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 14.0%
- Shares Outstanding
- 9.31B
- Float Shares
- 1.31B
Our AXIIF coverage
Recent articles, reports, and earnings notes.
No research on AXIIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AXIIF report →Alexium International Group Limited (AXIIF) Q4 2026 Earnings Call Transcript
seekingalpha.com · Sep 8
Alexium International Group Limited (AXIIF) Discusses Microtek Acquisition, Business Progress and Capital Raising Transcript
seekingalpha.com · May 8
Alexium International Group Limited (AXIIF) Discusses First Half Results, Microtek Acquisition, and Outlook for Business Recovery Prepared Remarks Transcript
seekingalpha.com · Mar 3
Alexium International Group Limited (AXIIF) Discusses Acquisition of Microencapsulation and PCM Businesses of Microtek and Associated Entitlement Offer Transcript
seekingalpha.com · Dec 15
Alexium International Group Limited (AXIIF) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com · Nov 20
Alexium International Group Limited (AXIIF) Q4 2025 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Oct 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.